MHUA צמיחה צפויה ברווח נקי למניה השנה meihuamed.com
MeihuaMed (MHUA) has established an extensive B2B distribution network for consumables, deeply integrating its catheters into hospital supply chains. The annual growth history of net income per share shows that the metric value is 0.00. While large Chinese factories ensure stability, a mono-dependence on disposable instruments and domestic market regulatory risks significantly reduce the overall profitability of the business.
פילוחים אנליטיים ודוחות נתונים של חברת Meihua Medical (MHUA)
MeihuaMed (MHUA) revenues depend on polymer costs and access to Western medical consumable markets. The eps_yy_co metric calculates the daily percentage deviation of current earnings per share from the same period last year. A narrowing of this range signals that the business is entering a stage of maturity and stagnating growth rates. It is critical for investors to avoid assets with zero yield. By analyzing the volatility of earnings per share compared to last year, one can assess the risk of capital freeze.
